CV Sciences Inc (CVSI): https://releaf.co.uk/education/medical/p...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

News Focus

News Focus

CV Sciences Inc (CVSI)

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	4
Posts	3185
Boards Moderated	0
Alias Born	08/23/2022

Re: Wolf-man jack post# 83561

Wednesday, 12/04/2024 8:44:08 AM

Wednesday, December 04, 2024 8:44:08 AM

https://releaf.co.uk/education/medical/pain/fibromyalgia/the-ideal-strength-of-cbd-oil-for-fibromyalgia

https://www.sciencedirect.com/science/article/pii/S2589986424000881

https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2024.1496473/abstract

https://www.mdpi.com/1422-0067/25/22/12453

https://www.biorxiv.org/content/10.1101/2024.09.26.615028v3

https://www.pluscbdoil.com/

https://ir.cvsciences.com/press-releases/detail/231/cv-sciences-inc-enters-into-definitive-agreement-to

https://governor.hawaii.gov/newsroom/news-release-doh-amends-administrative-rules-regarding-hemp-processing-and-manufactured-hemp-products/

Bullish

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent CVSI News

Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 08:10:09 PM
CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results • ACCESS Newswire • 05/14/2026 08:00:00 PM
CV Sciences, Inc. To Announce First Quarter 2026 Results On May 14, 2026 • ACCESS Newswire • 05/12/2026 10:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:04:10 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM

More CVSI News

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow